ClinConnect ClinConnect Logo
Search / Trial NCT06235710

Prevalence of Musculoskeletal Complaints in Nursing Home Residents

Launched by MAASTRICHT UNIVERSITY MEDICAL CENTER · Jan 23, 2024

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Rheumatic And Musculoskeletal Diseases Prevalence Nursing Home Residents

ClinConnect Summary

This clinical trial is studying joint pain and other musculoskeletal issues among nursing home residents, both those with and without dementia. The main goal is to find out how many residents have tender or swollen joints and how they feel about their joint pain. For residents who can communicate, the study will also look at their mobility and check if their medical records accurately describe their joint problems. Those with dementia will be asked simpler questions about their pain, while others will answer a few more detailed questions about their health and pain levels.

To participate, residents must be at least 65 years old. One group includes residents who are mentally competent and do not have dementia, while the other group includes residents diagnosed with dementia, whose legal representatives will provide consent. Participants will undergo a standard physical exam, and the study will ensure that no sensitive or intrusive questions are asked. The findings from this study could help improve the understanding and care of joint issues in nursing home residents.

Gender

ALL

Eligibility criteria

  • Inclusion criteria, group 1:
  • Mentally competent nursing home resident ≥ 65 years;
  • No diagnosis of dementia (major neurocognitive disorder according to DSM-5 criteria);
  • The nursing home resident provides informed consent to participate in the study.
  • Inclusion criteria, group 2:
  • Nursing home resident with dementia (major neurocognitive disorder according to DSM-5 criteria) ≥ 65 years;
  • The legal representative of the nursing home resident provides informed consent to participate in the study.
  • Exclusion criteria, group 1:
  • Diagnosis dementia;
  • Life expectancy \< 2 weeks (definition terminal nursing home resident). Exclusion criteria, group 2
  • Life expectancy \< 2 weeks (definition terminal nursing home resident).
  • If, on the basis of an already known pattern of behaviour, it is expected that the potential participant will resist the proposed research (anticipated behaviour).

About Maastricht University Medical Center

Maastricht University Medical Center (MUMC+) is a leading academic medical center in the Netherlands, renowned for its commitment to advancing healthcare through innovative research and education. As a prominent sponsor of clinical trials, MUMC+ integrates cutting-edge scientific inquiry with clinical practice, focusing on a wide range of medical disciplines. The center emphasizes collaboration among multidisciplinary teams, fostering an environment that promotes excellence in patient care and the translation of research findings into clinical applications. MUMC+ is dedicated to improving health outcomes and enhancing quality of life through rigorous clinical investigations and the development of novel therapeutic strategies.

Locations

Brunssum, Limburg, Netherlands

Patients applied

0 patients applied

Trial Officials

Marloes van Onna, MD; PhD

Principal Investigator

Maastricht University Medical Centre

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported